Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on 57 Freeway Near Chapman Avenue


Driver Arrested in Fatal Orange Accident

Fatal Accident 3

Orange, CA (March 8, 2020) – One person was killed and another was arrested in a crash in Orange. The fatal accident occurred on the morning of March 8 on the 57 Freeway.

A vehicle was driving on the southbound 57 Freeway, near Chapman Avenue, when it went off the road for unknown reasons. The vehicle hit a tree and burst into flames. The passenger died at the accident scene. The driver was arrested.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Orange

#92868


November 13, 2019

Woman Killed in Crash on Main Street

3 Vehicles Involved in Fatal Riverside Accident...


April 23, 2020

Pedestrian Killed in Crash on Main Street

Woman Hit by Car in Fatal Santa Ana Accident...


March 10, 2020

Woman Killed in Crash at Ave 184 and Road 64

Head-on Accident in Tulare Leads to Fatality...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.